Oral ketamine for the treatment of pain and treatment-resistant depression
The British Journal of Psychiatry February 1, 2016 Robert A Schoevers, Tharcila V. Chaves, Sonya M. Balukova et al. 80 citations
BACKGROUND: Recent studies with intravenous (i.v.) application of ketamine show remarkable but short-term success in patients with MDD. Studies in patients with chronic pain have used different ketamine applications for longer time periods. This experience may be relevant for psychiatric indications. AIMS: To review the literature about the dosing regimen, duration, effects and side-effects of...